Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG)VAMVAKAS, L; ATHANASIADIS, A; KARAMPEAZIS, A et al.Critical reviews in oncology/hematology. 2010, Vol 76, Num 1, pp 61-70, issn 1040-8428, 10 p.Article

Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancerKAKOLYRIS, S; KOUROUSSIS, Ch; SOUGLAKOS, J et al.Lung cancer. 2001, Vol 34, pp S71-S76, issn 0169-5002, SUP4Conference Paper

Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) : A phase II trialMAVROUDIS, D; KOUROUSIS, C; SARMONIS, G et al.American journal of clinical oncology. 2000, Vol 23, Num 4, pp 341-344, issn 0277-3732Article

First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbineKOUROUSIS, C; ANDROULAKIS, N; KAKOLYRIS, S et al.Cancer. 1998, Vol 83, Num 10, pp 2083-2090, issn 0008-543XArticle

Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy : A multicenter phase II studyANDROULAKIS, N; KOUROUSSIS, C; KOTSAKIS, A et al.Annals of oncology. 1998, Vol 9, Num 10, pp 1127-1130, issn 0923-7534Article

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)SOUGLAKOS, J; ZIRAS, N; GEORGOULIAS, V et al.British journal of cancer. 2012, Vol 106, Num 3, pp 453-459, issn 0007-0920, 7 p.Article

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use programPALLIS, A. G; MAVROUDIS, D; ANDROULAKIS, N et al.Lung cancer. 2003, Vol 40, Num 3, pp 301-307, issn 0169-5002, 7 p.Article

Phase I study of Paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) administered every 2 weeks in patients with advanced solid tumorsMAVROUDIS, D; KOUROUSSIS, Ch; KAKOLYRIS, S et al.Oncology. 2002, Vol 62, Num 3, pp 216-222, issn 0030-2414Article

A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapyKAKOLYRIS, S; SOUGLAKOS, J; AGELAKI, S et al.Lung cancer. 2000, Vol 30, Num 3, pp 193-198, issn 0169-5002Article

Spontaneous spondylodiscitis caused by Klebsiella pneumoniaeKOUROUSSIS, C; GEORGOULIAS, V; SOUGLAKOS, J et al.Infection. 1999, Vol 27, Num 6, pp 368-369, issn 0300-8126Article

IGF-I and IGF-II in relation to colorectal cancerMANOUSOS, O; SOUGLAKOS, J; BOSETTI, C et al.International journal of cancer. 1999, Vol 83, Num 1, pp 15-17, issn 0020-7136Article

Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)KATOPODIS, O; SOUGLAKOS, J; GEORGOULIAS, V et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 2, pp 333-340, issn 0344-5704, 8 p.Article

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLCKALIKAKI, A; KOUTSOPOULOS, A; TRYPAKI, M et al.British journal of cancer. 2008, Vol 99, Num 6, pp 923-929, issn 0007-0920, 7 p.Article

Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trialSOUGLAKOS, J; SYRIGOS, K; GEORGOULIAS, V et al.Annals of oncology. 2004, Vol 15, Num 8, pp 1204-1209, issn 0923-7534, 6 p.Article

Dose escalation study on oxaliplatin and Capecitabine (Xeloda) in patients with advanced solid tumorsKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2004, Vol 66, Num 4, pp 253-259, issn 0030-2414, 7 p.Article

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumoursANDROULAKIS, N; KOUROUSSIS, C; GEORGOULIAS, V et al.European journal of cancer (1990). 2002, Vol 38, Num 15, pp 1992-1997, issn 0959-8049Article

Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (cl) of 5-fluorouracil (5-Fu) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanesKALBAKIS, K; KOUROUSSIS, Ch; KAKOLYRIS, S et al.British journal of cancer. 2001, Vol 85, Num 6, pp 798-802, issn 0007-0920Article

Phase I study of the gemcitbine/oxaliplatin combination in patients with advanced solid tumors : A preliminary reportMAVROUDIS, D; KOUROUSIS, C; KAKOLYRIS, S et al.Seminars in oncology. 2000, Vol 27, Num 1, pp 25-30, issn 0093-7754, SUP2Article

Correlation of BRCAI , TXRI and TSPI mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancerPAPADAKI, C; TSAROUCHA, E; KAKLAMANIS, L et al.British journal of cancer. 2011, Vol 104, Num 2, pp 316-323, issn 0007-0920, 8 p.Article

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancerSOUGLAKOS, J; PHILIPS, J; FREED, E et al.British journal of cancer. 2009, Vol 101, Num 3, pp 465-472, issn 0007-0920, 8 p.Article

Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy : A Multicenter Phase II StudyKAKOLYRIS, S; SOUGLAKOS, J; VARDAKIS, N et al.Oncology. 2008, Vol 74, Num 1-2, pp 31-36, issn 0030-2414, 6 p.Article

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIR (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC) : a multicentre randomised phase iii trial from the Hellenic Oncology Research Group (HORG)SOUGLAKOS, J; ANDROULAKIS, N; KALYKAKI, A et al.British journal of cancer. 2006, Vol 94, Num 6, pp 798-805, issn 0007-0920, 8 p.Article

Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer : A phase II trialSOUGLAKOS, J; PALLIS, A; KAKOLYRIS, S et al.Oncology. 2005, Vol 69, Num 5, pp 384-390, issn 0030-2414, 7 p.Article

A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancerKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2001, Vol 60, Num 3, pp 207-213, issn 0030-2414Article

Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatinKAKOLYRIS, S; KOUROUSSIS, C; KALBAKIS, K et al.Annals of oncology. 2000, Vol 11, Num 6, pp 757-760, issn 0923-7534Article